ULTIMO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 543
EU - Europa 169
AS - Asia 68
AF - Africa 14
SA - Sud America 6
OC - Oceania 3
Totale 803
Nazione #
US - Stati Uniti d'America 540
IT - Italia 59
FR - Francia 39
VN - Vietnam 26
CN - Cina 21
PL - Polonia 20
BG - Bulgaria 11
DE - Germania 10
RU - Federazione Russa 6
SE - Svezia 6
ZA - Sudafrica 5
CI - Costa d'Avorio 4
CL - Cile 4
FI - Finlandia 4
GB - Regno Unito 4
HK - Hong Kong 4
IR - Iran 4
AU - Australia 3
IN - India 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
MX - Messico 2
NL - Olanda 2
QA - Qatar 2
UA - Ucraina 2
BO - Bolivia 1
BR - Brasile 1
CA - Canada 1
DK - Danimarca 1
ES - Italia 1
GH - Ghana 1
GR - Grecia 1
IQ - Iraq 1
KR - Corea 1
PT - Portogallo 1
TR - Turchia 1
Totale 803
Città #
Santa Cruz 72
Ashburn 68
Fairfield 52
Houston 37
Woodbridge 30
Dong Ket 26
Cambridge 24
Ferrara 23
Des Moines 21
Warsaw 20
Seattle 18
Buffalo 16
Wilmington 14
Las Vegas 10
Shanghai 10
Ann Arbor 9
Chicago 7
Los Angeles 6
Saint Petersburg 6
San Diego 6
Muizenberg 5
San Jose 5
Abidjan 4
Boardman 4
Cittadella 4
Columbus 4
Guangzhou 4
Helsinki 4
Lake Forest 4
Stockholm 4
San Francisco 3
Shenyang 3
Sistov 3
Sydney 3
Vicenza 3
Arlington 2
Aurora 2
Clearwater 2
Doha 2
Este 2
Frankfurt Am Main 2
Frankfurt am Main 2
Gonder 2
Hong Kong 2
New York 2
Paris 2
Santiago 2
's-Hertogenbosch 1
Acapulco de Juárez 1
Amsterdam 1
Banha 1
Bengaluru 1
Bilecik 1
Bologna 1
Cairo 1
Campbellsville 1
Carteret 1
Central 1
Council Bluffs 1
Dulles 1
Florence 1
Fortaleza 1
Frederick 1
Gothenburg 1
Henderson 1
Icheon-si 1
Kamoikechō 1
La Paz 1
Lombard 1
London 1
Ma Liu Shui 1
Madrid 1
Marietta 1
Mizonuma 1
Nanjing 1
Newmarket 1
Palo Alto 1
Pavia 1
Plano 1
Portland 1
Porto 1
Randers 1
Reston 1
Rio Grande 1
Riva 1
Rochester 1
Rome 1
Rovigo 1
Salt Lake City 1
Scarsdale 1
Scranton 1
Southampton 1
Tabriz 1
Thessaloniki 1
Zibo 1
Totale 604
Nome #
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines, file e309ade1-50ca-3969-e053-3a05fe0a2c94 103
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model, file e309ade1-dfbb-3969-e053-3a05fe0a2c94 95
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise, file e309ade1-c7b1-3969-e053-3a05fe0a2c94 94
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells, file e309ade0-825e-3969-e053-3a05fe0a2c94 73
Impact of physical exercise in cancer survivors during and after antineoplastic treatments, file e309ade1-b725-3969-e053-3a05fe0a2c94 69
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia, file e309ade1-c418-3969-e053-3a05fe0a2c94 66
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia, file e309ade3-b28c-3969-e053-3a05fe0a2c94 65
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia, file e309ade0-8149-3969-e053-3a05fe0a2c94 64
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia, file e309ade1-c41a-3969-e053-3a05fe0a2c94 63
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments, file e309ade1-c529-3969-e053-3a05fe0a2c94 58
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases, file e309ade1-c692-3969-e053-3a05fe0a2c94 55
Inhibition of the PI3K/Akt/mTOR signaling pathway as a therapeutic target for Acute Lymphoblastic Leukemia, file e309ade5-5408-3969-e053-3a05fe0a2c94 10
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia, file e309ade1-c7af-3969-e053-3a05fe0a2c94 5
Inhibition of the PI3K/Akt/mTOR signaling pathway as a therapeutic target for Acute Lymphoblastic Leukemia, file e309ade5-8116-3969-e053-3a05fe0a2c94 3
Totale 823
Categoria #
all - tutte 3.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 1 0 0 0 0 0 0 0 0 4 1 12
2020/2021267 1 3 1 2 60 21 23 46 8 43 11 48
2021/2022169 6 4 10 0 12 12 8 4 5 24 58 26
2022/2023178 12 7 58 35 4 15 21 4 0 3 16 3
2023/2024180 0 0 14 18 18 19 37 22 19 28 5 0
Totale 823